Shukla R - Search Results

1

Vincristine-based nanoformulations: a preclinical and clinical studies overview.

Shukla R, Singh A, Singh KK. Shukla R, et al. Drug Deliv Transl Res. 2024 Jan;14(1):1-16. doi: 10.1007/s13346-023-01389-6. Epub 2023 Aug 8. Drug Deliv Transl Res. 2024. PMID: 37552393 Free PMC article. Review.

2

Temperature/pH-Triggered PNIPAM-Based Smart Nanogel System Loaded With Anastrozole Delivery for Application in Cancer Chemotherapy.

Singh A, Vaishagya K, K Verma R, Shukla R. Singh A, et al. Among authors: shukla r. AAPS PharmSciTech. 2019 Jun 4;20(5):213. doi: 10.1208/s12249-019-1410-3. AAPS PharmSciTech. 2019. PMID: 31165298

3

Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges.

Kashyap K, Shukla R. Kashyap K, et al. Among authors: shukla r. Curr Drug Deliv. 2019;16(10):887-901. doi: 10.2174/1567201816666191029122740. Curr Drug Deliv. 2019. PMID: 31660815 Review.

4

Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity.

Singh A, Kumar A, Verma RK, Shukla R. Singh A, et al. Among authors: shukla r. Int J Biol Macromol. 2020 Apr 15;149:1198-1206. doi: 10.1016/j.ijbiomac.2020.02.041. Epub 2020 Feb 7. Int J Biol Macromol. 2020. PMID: 32044368

5

Box-Behnken Design Optimized TPGS Coated Bovine Serum Albumin Nanoparticles Loaded with Anastrozole.

Kumar A, Singh A, Flora SJS, Shukla R. Kumar A, et al. Among authors: shukla r. Curr Drug Deliv. 2021;18(8):1136-1147. doi: 10.2174/1567201818666210202104810. Curr Drug Deliv. 2021. PMID: 33530907

6

Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis.

Shukla R, Singh A, Handa M, Flora SJS, Kesharwani P. Shukla R, et al. Drug Discov Today. 2021 Aug;26(8):1972-1979. doi: 10.1016/j.drudis.2021.04.011. Epub 2021 Apr 20. Drug Discov Today. 2021. PMID: 33892144 Review.

7

Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting.

Handa M, Beg S, Shukla R, Barkat MA, Choudhry H, Singh KK. Handa M, et al. Among authors: shukla r. J Control Release. 2021 Dec 10;340:48-59. doi: 10.1016/j.jconrel.2021.10.025. Epub 2021 Oct 23. J Control Release. 2021. PMID: 34695523 Review.

8

Drug repurposing strategies and key challenges for COVID-19 management.

Mule S, Singh A, Greish K, Sahebkar A, Kesharwani P, Shukla R. Mule S, et al. Among authors: shukla r. J Drug Target. 2022 Apr;30(4):413-429. doi: 10.1080/1061186X.2021.2013852. Epub 2021 Dec 9. J Drug Target. 2022. PMID: 34854327 Review.

9

Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.

Handa M, Singh A, Flora SJS, Shukla R. Handa M, et al. Among authors: shukla r. Curr Pharm Des. 2022;28(11):910-921. doi: 10.2174/1381612827666211208150210. Curr Pharm Des. 2022. PMID: 34879797 Review.

10

Box-Behnken design optimized silibinin loaded glycerylmonooleate nanoliquid crystal for brain targeting.

Singh A, Vaish A, Shukla R. Singh A, et al. Among authors: shukla r. Chem Phys Lipids. 2022 May;244:105193. doi: 10.1016/j.chemphyslip.2022.105193. Epub 2022 Mar 9. Chem Phys Lipids. 2022. PMID: 35278428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,947 results

Search Page

Filters